Growth Metrics

Fulgent Genetics (FLGT) Long-Term Investments (2016 - 2025)

Fulgent Genetics' Long-Term Investments history spans 9 years, with the latest figure at $369.3 million for Q4 2025.

  • For Q4 2025, Long-Term Investments fell 35.26% year-over-year to $369.3 million; the TTM value through Dec 2025 reached $369.3 million, down 35.26%, while the annual FY2025 figure was $369.3 million, 35.26% down from the prior year.
  • Long-Term Investments for Q4 2025 was $369.3 million at Fulgent Genetics, down from $411.8 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $602.2 million in Q3 2024 and bottomed at $287.6 million in Q1 2021.
  • The 5-year median for Long-Term Investments is $413.7 million (2022), against an average of $435.8 million.
  • The largest annual shift saw Long-Term Investments surged 1302.73% in 2021 before it tumbled 35.26% in 2025.
  • A 5-year view of Long-Term Investments shows it stood at $485.0 million in 2021, then tumbled by 32.66% to $326.6 million in 2022, then increased by 29.67% to $423.6 million in 2023, then soared by 34.65% to $570.4 million in 2024, then crashed by 35.26% to $369.3 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Long-Term Investments are $369.3 million (Q4 2025), $411.8 million (Q3 2025), and $484.5 million (Q2 2025).